Related Experiment Video
Updated: May 10, 2026
08:56
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
[Amiodarone administered orally or intravenously - the same or different drug?]
Dariusz A Kosior1, Agnieszka Krzykwa, Marek Postuła
1dkosior@acn.waw.pl
Summary
Amiodarone effectively manages tachycardias through distinct acute and chronic mechanisms. Understanding its pharmacokinetics, including enterohepatic circulation and active metabolites, is crucial for effective antiarrhythmic therapy.
Area of Science:
- Pharmacology
- Clinical Practice
- Cardiac Electrophysiology
Background:
- Amiodarone is a widely used antiarrhythmic drug for supraventricular and ventricular tachycardias.
- It exhibits variable oral bioavailability and undergoes significant enterohepatic circulation.
- A large first-pass effect produces the active metabolite desethylamiodarone.
Discussion:
- Acute amiodarone therapy inhibits sodium and calcium currents and exhibits alpha- and beta-blockade.
- Chronic amiodarone therapy primarily inhibits potassium currents, prolonging action potential duration in cardiac tissues.
- These effects differ significantly between acute and chronic administration.
Key Insights:
- Desethylamiodarone shares electrophysiologic properties with amiodarone.
- Acute effects involve ion channel blockade and adrenergic blockade.
- Chronic effects focus on potassium channel inhibition and action potential prolongation.
Outlook:
- Understanding amiodarone's pharmacokinetics is essential for clinicians.
- Knowledge of its pharmacokinetic profile aids in optimizing antiarrhythmic treatment.
- Further research into optimizing amiodarone dosing and monitoring is warranted.
More Related Videos
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:28IV Infusion to Oral Dosing: Conversion Methods
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...